Evidence map›Paper›PMID 31591113›Full record

ArticleAntimicrobial agents and chemotherapy2019

No evidence of

Kevin Wamae, Dorcas Okanda, Leonard Ndwiga, Victor Osoti, Kelvin M Kimenyi, Abdirahman I Abdi, Philip Bejon, Colin Sutherland, Lynette Isabella Ochola-Oyier

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Putative molecular markers ofFrontiers in epidemiology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Impact of Intermittent Presumptive Treatment for Malaria in Pregnancy on Hospital Birth Outcomes on the Kenyan Coast.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Kevin WamaeKEMRI-Wellcome Trust Research Programme, CGMRC, Kenya.ORCID http://orcid.org/0000-0001-7721-5534
Dorcas OkandaCentre for Biotechnology and Bioinformatics, University of Nairobi, Kenya.
Leonard NdwigaKEMRI-Wellcome Trust Research Programme, CGMRC, Kenya.
Victor OsotiKEMRI-Wellcome Trust Research Programme, CGMRC, Kenya.
Kelvin M KimenyiKEMRI-Wellcome Trust Research Programme, CGMRC, Kenya.
Abdirahman I AbdiKEMRI-Wellcome Trust Research Programme, CGMRC, Kenya.
Philip BejonKEMRI-Wellcome Trust Research Programme, CGMRC, Kenya.
Colin SutherlandDepartment of Immunology and Infection, Faculty of Infectious Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom.
Lynette Isabella Ochola-OyierKEMRI-Wellcome Trust Research Programme, CGMRC, Kenya.
Kenya Medical Research Institute · KEPwani University · KEUniversity of Nairobi · KEChurchill Hospital · GBLondon School of Hygiene & Tropical Medicine · GB

Funding

Wellcome Trust 107568
6 · The paper itself

Abstract

Antimalarial drug resistance is a substantial impediment to malaria control. The spread of resistance has been described using genetic markers which are important epidemiological tools. We carried out a temporal analysis of changes in allele frequencies of 12 drug resistance markers over two decades of changing antimalarial drug policy in Kenya. We did not detect any of the validated

Identifiers

PMID31591113
PMCPMC6879256
OpenAlexW2990200082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.